Acumen Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.48

-0.09 (-3.50%)

As of May 16, 2:09 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +796.0% upside

Low Target $18.81

Average Target $22.22

High Target $35.10

Current Price $2.48

Current
$2.48

Target
$22.22

$18.81 $22.22 avg $35.10

Scenario Analysis

Bear Case

$18.81

658.5%

Low target

Base Case

$22.22

+796.0%

Avg target

Bull Case

$35.10

+1,315.3%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$3.60

-31.1% from high

52-Week Low

$0.97

+155.4% from low

Target vs 52W High

$22.22

+517.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%